Infusive Asset Management’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.24M Sell
57,043
-20,558
-26% -$3.12M 3.99% 10
2025
Q4
$11.1M Buy
77,601
+28,055
+57% +$4.14M 4.75% 6
2025
Q3
$7.61M Sell
49,546
-9,882
-17% -$1.54M 3.49% 9
2025
Q2
$9.47M Sell
59,428
-15,295
-20% -$2.5M 4.22% 7
2025
Q1
$12.7M Buy
74,723
+15,096
+25% +$2.53M 5.91% 5
2024
Q4
$10M Sell
59,627
-9,493
-14% -$1.62M 4.45% 7
2024
Q3
$12M Buy
69,120
+16,040
+30% +$2.72M 5.05% 6
2024
Q2
$8.75M Sell
53,080
-16,648
-24% -$2.72M 3.53% 12
2024
Q1
$11.3M Sell
69,728
-100
-0.1% -$15.7K 4.36% 13
2023
Q4
$10.2M Buy
+69,828
New +$10.3M 4.64% 13

Other funds holding PG

Infusive Asset Management's PG Position: Q1 2026 in Review

Infusive Asset Management reduced its Procter & Gamble (PG) stake by 26% in Q1 2026, selling an estimated $3.12M and leaving 57,043 shares worth $8.24M. The position accounts for 3.99% of the portfolio, ranked #10.

Infusive Asset Management first reported a position in PG in Q4 2023 and has held it in 10 quarters since. The position peaked at $12.7M in Q1 2025. 3,986 funds tracked by Wall St. Rank hold PG as of Q1 2026.

  • Infusive Asset Management held 57,043 shares of Procter & Gamble worth $8.24M as of Q1 2026.
  • Infusive Asset Management sold 20,558 Procter & Gamble shares in Q1 2026, an estimated $3.12M.
  • Procter & Gamble made up 3.99% of Infusive Asset Management's portfolio in Q1 2026, its #10 holding.
  • Infusive Asset Management first reported a position in Procter & Gamble in Q4 2023 and has held it in 10 quarters since.
  • Infusive Asset Management's Procter & Gamble position peaked at $12.7M in Q1 2025.
  • 3,986 funds tracked by Wall St. Rank held Procter & Gamble as of Q1 2026.

Based on Infusive Asset Management's 13F filing for Q1 2026, filed 14 May 2026.